Skip to content

Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery

A Monocentric, Comparative and Randomized Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03823963
Acronym
MEPICARD
Enrollment
478
Registered
2019-01-31
Start date
2018-12-10
Completion date
2020-01-31
Last updated
2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcers, Prevention, Skin Ulcer, Ulcer

Brief summary

The study is a randomised controlled trial of patients admitted for a scheduled cardiac surgery at the Clermont-Ferrand hospital. Patients meeting the study inclusion criteria will be allocated to either the control group that will receive pressure ulcer prevention standard care or the intervention group that will receive pressure ulcer prevention standard care plus have a Mepilex® Border dressing applied to their sacrum.

Detailed description

The main objective of this research is to evaluate the impact of Mepilex Border® dressing applied in addition to standard pressure ulcer prevention protocol, in a French hospital setting, in at-risk patients in a cardiovascular surgery unit with full hospitalisation including block operation and ICU. Hypothesis: Patients treated with Mepilex® Border dressings will have a lower incidence rate of sacral pressure ulcer development than patients receiving standard care.

Interventions

COMBINATION_PRODUCTMepilex® Border dressing

Soft silicone self-adherent dressing (5-layers)

OTHERStandard care

The control group will receive pressure ulcer prevention standard care

Sponsors

Molnlycke Health Care AB
CollaboratorINDUSTRY
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject over 18 years of age, * Subject programmed to benefit from cardiac surgery with sternotomy, * Subject capable and willing to comply with the protocol and willing to give his written consent, * Subject affiliated to a social security system

Exclusion criteria

* Subject with a skin lesion in the sacral area upon admission, * Subject admitted for emergency cardiovascular surgery (unscheduled subject), * Subject admitted for heart transplant surgery, * Subject participating in another clinical study or in a period of exclusion from a study previous, * Subject with a linguistic or psychological disability to sign informed consent, * Subject refusing to give written consent, * Subject deprived of liberty by administrative or judicial decision, under guardianship or curatorship.

Design outcomes

Primary

MeasureTime frameDescription
Pressure ulcer incidence0-20 daysIncidence of sacral pressure ulcers acquired during patients' hospital stay

Countries

France

Contacts

Primary ContactLise LACLAUTRE
drci@chu-clermontferrand.fr04 73 75 49 63

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026